Your browser doesn't support javascript.
loading
Brominated Depsidones with Antibacterial Effects from a Deep-Sea-Derived Fungus Spiromastix sp.
Huang, Zequan; Liu, Dong; Chen, Shang; Ren, Jinwei; Gao, Chenghai; Li, Zhiyong; Fan, Aili; Lin, Wenhan.
Afiliação
  • Huang Z; State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
  • Liu D; Institute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.
  • Chen S; State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
  • Ren J; State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
  • Gao C; State Key Laboratory of Mycology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.
  • Li Z; Institute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.
  • Fan A; State Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China.
  • Lin W; State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
Mar Drugs ; 22(2)2024 Feb 03.
Article em En | MEDLINE | ID: mdl-38393049
ABSTRACT
Eleven new brominated depsidones, namely spiromastixones U-Z5 (1-11) along with five known analogues (12-16), were isolated from a deep-sea-derived fungus Spiromastix sp. through the addition of sodium bromide during fermentation. Their structures were elucidated by extensive analysis of the spectroscopic data including high-resolution MS and 1D and 2D NMR data. Compounds 6-10 and 16 exhibited significant inhibition against Gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecium (VRE) with MIC values ranging from 0.5 to 2.0 µM. Particularly, tribrominated 7 displayed the strongest activity against MRSA and VRE with a MIC of 0.5 and 1.0 µM, respectively, suggesting its potential for further development as a new antibacterial agent.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Depsídeos / Staphylococcus aureus Resistente à Meticilina Idioma: En Revista: Mar Drugs Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Depsídeos / Staphylococcus aureus Resistente à Meticilina Idioma: En Revista: Mar Drugs Ano de publicação: 2024 Tipo de documento: Article